A rapid and sensitive modified HPLC method for determination of diclofenac in human plasma and its application in pharmacokinetic studies

Daru

Volumn 15, Issue 3, 2007, Pages 132-138

  Emami, J ^a   Ghassami, N ^a   Talari, R ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioequivalence; Chromatography; Diclofenac; HPLC

Indexed keywords

2 PROPANOL; ACETONITRILE; DICLOFENAC; HEXANE; NAPROXEN; NITROGEN; PHOSPHORIC ACID;

ADULT; ARTICLE; BIOEQUIVALENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; QUANTITATIVE ANALYSIS; RANDOMIZATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE DRUG DOSE;

EID: 35848956096     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Reynolds, JEF. Martindale, The Extra Pharmacopoeia, Vol. 33, pp 30-32, The Royal Pharmaceutical Society, Great Britain, London, 2002.
2. th ed. New York, Mc Graw - Hill, 2001, pp 598-99, 604.
3. Ku EC, Wasvary JM, Cash WD. Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase. Biochem. Pharmacol. 1985; 24: 641-643.
4. Menasse R, Hedwall PR, Kraetz J, Pericin C, Riesterer L, Sallmann A, Ziel R, Jaques R. Pharmacological properties of diclofenac sodium and its metabolites. Scand. J. Rheumatol. 1978; 22: 5-16.
5. Brogen RN, Heel RC, Pakes GE, Speight TM, Avery GS. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.1980; Drugs 20: 24-48.
6. Hasan MM, Najib NM, Rawashdeh, NM, Sallam EN, Shubair MS, Alawneh Y. Comparative bioavailability of two tablet formulations of diclofenac sodium in normal subjects. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991; 29: 178-183.
7. Fowler PD, Shadforth MF, Crook PR, John VA. Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur. J. Clin. Pharmacol. 1983; 25: 389-394.
8. Willis JV, Kendall MJ, Flinn RM, Thornik DP, Welling PG. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur. J. Clin. Pharmacol. 1979; 16: 405-410.
9. Benson MD, Aldo-Benson M, Brandt KD. Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis. Semin. Arthritis Rheum. 1985; 15: 65-67.
10. Chan KKH, Vyas KH, Brand KD. In vitro protein binding of diclofenac sodium in plasma and synovial fluid. J. Pharm. Sci. 1987; 76: 105-108.
11. Wallis WJ, Simkin PA. Antirheumatic drug concentration in human synovial fluid and synovial tissue: observation on extravascular pharmacokinetics. Clin. Pharmacokinet. 1983; 8: 496-522.
12. Arcelloni C, Lanzi R, Pedercini S, Molteni G, Fermo I, Pontiroli A, Paroni R. High performance liquid chromatographic determination of diclofenac in human plasma after solid-phase extraction. J. Chromatogr. B 2001; 763: 195-200.
13. Terhaag B, Gramatte T, Hrdlcka P, Richter K, Feller K. The influence of food on the absorption of diclofenac as a pure substance. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991; 29: 418-421.
14. Eranko PO, Palva, ES, Konno K, Venho VMK. Regulatory control of synonym drug bioavailability: Bioinequivalency of Nifedipine preparations. Pharmaceutic Med. 1990; 4: 197-205.
15. Emami J, Varshosaz J, Flamarzian M, Tahvilian R. High performance liquid chromatographic determination, pharmacokinetic and comparative bioavailability studies of cisapride. J. Pharm. Biomed. Anal. 2003; 33: 513-520.
16. Avgerinos A, Karidas T, Malamataris S. Extractionles high-performance liquid chromatographic methodfor the determination of diclofenac in human plasma and urine. J. Chromatogr. 1993; 619(2): 324-329.
17. El-Sayed YM, Abdel-Hameed ME, Suleiman MS, Najib NM. A rapid and sensitive high-performance liquid chromatographic method for the determination of diclofenac sodium in serum and its use in pharmacokinetic studies. J. Pharm. Pharmacol. 1988; 40 (10): 727-729.
18. Moncrieff J. Extractionless determination of diclofenac sodium in serum using reversed-phase high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. 1992; 577 (1): 185-189.
19. Hiari T, Matsumuto S, Kishi I. Simultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extraction. J. Chromatogr. B Biomed. Sci. Appl. 1997; 692: 375-88.
20. Millership JS, Hare LG, Farry m, Collier PS, McElnay JC, Shields MD, Carson DJ. The use of hydrophilic lipophilic balance copolymer SPE cartridges for the extraction of diclofenac from small volume pediatric plasma samples. J. of Pharm. Biomed. Analysis. 2001; 25: 871-879.
21. Mason JL, Hobbs GJ, A rapid high performance liquid chromatographic assay for the measurement of diclofenac in human plasma. J. Liq. Chromatogr. 1995; 18: 2045-2058.
22. Zecca L, Ferrario P, Costi P. Determination of diclofenac and its metabolites in plasma and cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 1991; 567(2): 425-432.
23. Torres-Lopez JE, Robles MB, Perez-Urizar J, Flores-Murrieta FJ, Granados-Soto V. Determination of diclofenac in micro-whole blood samples by high-performance liquid chromatography with electrochemical detection. Application in a pharmacokinetic study. Arzneimittelforschung. 1997; 47(9): 1040-1043.
24. Blaghrough IS, Daykin MM, Doherty M, Patrick M, Shaw PN. High performance liquid chromatographic determination of naproxen, Ibuprofen and diclofenac in plasma and synovial fluid in man. J. Chromatogr. 1992; 578: 251-257.
25. Giagoudakis G, Markantonis SL. An alternative high-performance liquid chromatographic method for the determination of diclofenac and flurbiprofen in plasma. J. Pharm. Biomed. Anal. 1998; 17(4-5): 897-901.
26. Roskar R, Kmetec V. Liquid chromatographic determination of diclofenac in human synovial fluid. J. Chromatogr. B 2003; 788: 57-64.
27. Plavsic F, Cullig j. Determination of serum diclofenac by high-performance liquid chromatography by electrochemical detection. Hum. Toxicol. 1985; 4(3): 317-322.
28. Lee HS, Kim EJ, Zee OP, Lee YJ. High performance liquid chromatographic determination of diclofenac sodium in plasma using column-switching technique for sample clean-up. Arch Pharm. 1989; 322: 801-806.
29. Lee HS, Jeong CK, Choi SJ, Kim BS, Lee MH, Ko GI, Sohn DH. Simultaneous determination of aceclofenac and diclofenac in human plasma by narrowbore HPLC using column switching. 2000; 23: 775-781.
30. Westlake WJ. Use of confidence intervals in analysis of comparative bioavailability trials. J. Pharm. Sci. 1972; 61(8): 1340-1341.